72.11.Z - Research and experimental development on biotechnology
62.01.Z - Computer programming activities
62.02.Z - Computer consultancy activities
62.09.Z - Other information technology and computer service activities
70.22.Z - Business and other management consultancy activities
72.19.Z - Other research and experimental development on natural sciences and engineering
86.21.Z - General medical practice activities
86.22.Z - Specialist medical practice activities
86.90.C - Nurses and midwives activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 0 | 0 | 0 | 0 |
EBITDA | 0 | 0 | 0 | 0 |
Short time liabilities | 0 | 0 | 0 | 0 |
Equity capital | 0 | 0 | 0 | 0 |
Operating profit (EBIT) | 0 | 0 | 0 | 0 |
Assets | 0 | 0 | 0 | 0 |
Net profit (loss) | 0 | 0 | 0 | 0 |
Cash | 0 | 0 | 0 | 0 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 0 | 0 | 0 | 0 |
Working assets | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -86,1 | |||
Equity capital to total assets | -17,6 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 | 0 | 0 | 0 |
Current financial liquidity indicator | -0,5 | |||
Net dept to EBITDA | 1,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane